SCHEMBL24635508

SCHEMBL24635508

COc1ccc(C2(N)CC2)cc1C=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
TSHR P16473 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 2/20 0.41
HPGD P15428 2/20 0.41
TUBB1 Q9H4B7 1/20 0.40
AOX1 Q06278 1/20 0.40
MAPT P10636 1/20 0.39
PRKDC P78527 1/20 0.39
FDPS P14324 1/20 0.38
ERN1 O75460 3/20 0.38
MAOA P21397 1/20 0.37
TLR2 O60603 1/20 0.37
TLR1 Q15399 1/20 0.37
TLR6 Q9Y2C9 1/20 0.37
TRIM24 O15164 1/20 0.37
ALDH5A1 P51649 1/20 0.37
ABAT P80404 1/20 0.37
TRIM33 Q9UPN9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL194592 0.81 ALDH1A1 (0.46) ALDH1A1TSHRTDP1KDM4ELMNA
SCHEMBL10321078 0.79 ALDH1A1 (0.44) ALDH1A1TSHRTDP1KDM4ELMNA
SCHEMBL7586055 0.77 PDE4B (0.48) ALDH1A1TSHRTDP1KDM4E
SCHEMBL23802086 0.77 ALDH1A1 (0.42) ALDH1A1TSHRTDP1KDM4ELMNA
SCHEMBL10320513 0.76 ALDH1A1 (0.41) ALDH1A1TSHRTDP1KDM4ELMNA
SCHEMBL11185676 0.75 ALDH1A1 (0.43) ALDH1A1TSHRTDP1KDM4ELMNA
SCHEMBL7586053 0.75 MEN1 (0.51) ALDH1A1TSHRTDP1KDM4ELMNA
SCHEMBL20379847 0.75 LMNA (0.43) ALDH1A1TSHRTDP1KDM4ELMNA
SCHEMBL23231388 0.75 KDM1A (0.46) ALDH1A1LMNATUBB1MAOASMN1; SMN2
SCHEMBL30089510 0.74 KMT2A (0.47) ALDH1A1TSHRTDP1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226408-A1 NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2022-10-27 WO disclosed